|
|
|
GTCbio, Washington, D.C.
November 12-14, 2008
PRE-CONFERENCE WORKSHOP - November 12, 2008
Funding Strategies
• Funding from NIH, HHS, CDC, and other Government Agencies • Funding from NGOs - What Roles do the NGOs Play? • How to Get Funding to Produce Vaccines that Have Low Market Presence
MAIN CONFERENCE - November 13-14, 2008
Session I: Vaccines for Infectious Diseases • HPV Vaccine • Meningitis Vaccine • Rotavirus Vaccine • Ecoli Based Cholera Vaccines and Cephalitis • Old Disease – New Threat: Tuberculosis • AIDS Vaccine Update • HIV Vaccine Update • New Antigens
Session II: Vaccines for Non-Infectious Diseases • Immuno-Therapeutics • Allergy Vaccine • Cancer Vaccine – Breast Cancer, Colon Cancer, • Anti-Smoking “Vaccine” • blood Pressure Vaccine • Immuno-Modulator • DNA Vaccine
Session III: New Technologies in Vaccine Development • In-Vitro Human Immune System • Adjuvants • Novel Drug Delivery • New Developments in Stability, • Safety/Toxicology
Session IV: Future Trends in Vaccine Discovery • Next Generation Vaccine Design – What Does the Future Hold? (Genomics/Screening Technology) • India, China – What Impact will they Have on the Vaccines Market?
Session V: Regulatory & Government Policy • Policy – Legislation, Regulation of Safety • Business Alliances / Mergers – Impact and Strategies… • FDA approvals – what is necessary • National Vaccine Plan - Sub Topic - Influenza Pandemic • Current Status of Flu Vaccines • Developments in US versus EU • Universal Vaccination
|
|
|
|
|
|
Organized by:
|
|
GTCbio |
|
Invited Speakers:
|
|
Natalie Garcon, PharmD, Ph.D. Vice President and Head of Research GSK Biologicals
|
|
|
|
|
|
Deadline for Abstracts:
|
|
October 12, 2008
|
|
|
|
|
|
Registration:
|
|
Register by September 12 for a 20% Discount.
|
|
E-mail:
|
|
raniah@gtcbio.com
|
|
|
|
|
|
|
|